Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Mumbai, October 28: Piramal Pharma Limited a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026. Consolidated Financial Highlights (in ₹ Crores or as stated) Particulars Q2FY27 Q2FY26 YoY Growth H1FY27 H1FY26 YoY Growth Revenue from…